Sweden· SE-20131130000029
Xydalba 500 mg Pulver till koncentrat till infusionsvätska, lösning
A medicinal product containing dalbavancin, registered in Sweden by AbbVie Deutschland GmbH & Co KG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Dalbavancin
- Manufacturer
- AbbVie Deutschland GmbH & Co KG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20131130000029
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dalbavancin in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainDALBAVANCINA ACCORD 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- United KingdomDalbavancin 500mg powder for concentrate for solution for infusion vialsZentiva Pharma UK Ltd
- PolandDalbavancin AccordAccord Healthcare Polska Sp. z o.o.
- IcelandXydalbaAbbVie Deutschland GmbH & Co. KG
- FinlandXydalbaAbbVie Deutschland GmbH&Co.KG
- NorwayXydalbaAbbVie Deutschland GmbH & Co
- FranceDALBAVANCINE ACCORD 500 mg, poudre pour solution à diluer pour perfusionACCORD HEALTHCARE FRANCE
- GermanyDalbavancin AccordAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Dalbavancin, Dalbavancin Accord
- Germany · Dalbavancin Accord, Dalbavancin Baxter
- Denmark · Dalbavancin Adalvo, Dalbavancin Teva
- Spain · Dalbavancin Dr. Reddys, Dalbavancina Accord
- Finland · Dalbavancin Adalvo, Dalbavancin Tillomed
- France · Dalbavancine Accord, Dalbavancine Reddy Pharma
- United Kingdom (Northern Ireland) · Dalbavancin Accord, Dalbavancin Reig Jofre Uk
- Greece · Bavalda, Dalbavancin Accord
- Iceland · Xydalba
- Italy · Dalbavancina Accord, Dalbavancina Dr. Reddy’s
- Liechtenstein · Xydalba
- Malta · Bavalda, Dalbavancin Adalvo
- Norway · Dalbavancin Tillomed, Xydalba
- Poland · Dalbavancin Accord, Dalbavancin Reig Jofre
- Portugal · Dalbavancina Anfarm
- Slovakia · Dalbavancin Adalvo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b25006e5-5946-40f5-a7d7-1c65ef4e4f37 GET /v1/drugs/b25006e5-5946-40f5-a7d7-1c65ef4e4f37?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20131130000029",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20131130000029",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/xydalba-epar-product-information_sv.pdf"
}See everything about dalbavancin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.